Literature DB >> 14506037

Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.

Omar N Al Safarjalani1, Fardos N M Naguib, Mahmoud H El Kouni.   

Abstract

Intracellular Toxoplasma gondii grown in human foreskin fibroblast cells transported nitrobenzylthioinosine [NBMPR; 6-[(4-nitrobenzyl)mercapto]-9-beta-D-ribofuranosylpurine], an inhibitor of nucleoside transport in mammalian cells, as well as the nonphysiological beta-L-enantiomers of purine nucleosides, beta-L-adenosine, beta-L-deoxyadenosine, and beta-L-guanosine. The beta-L-pyrimidine nucleosides, beta-L-uridine, beta-L-cytidine, and beta-L-thymidine, were not transported. The uptake of NBMPR and the nonphysiological purine nucleoside beta-L-enantiomers by the intracellular parasites also implies that Toxoplasma-infected cells can transport these nucleosides. In sharp contrast, under the same conditions, uninfected fibroblast cells did not transport NBMPR or any of the unnatural beta-L-nucleosides. beta-D-Adenosine and dipyridamole, another inhibitor of nucleoside transport, inhibited the uptake of NBMPR and beta-L-stereoisomers of the purine nucleosides by intracellular Toxoplasma and Toxoplasma-infected cells. Furthermore, infection with a Toxoplasma mutant deficient in parasite adenosine/purine nucleoside transport reduced or abolished the uptake of beta-D-adenosine, NBMPR, and purine beta-L-nucleosides. Hence, the presence of the Toxoplasma adenosine/purine nucleoside transporters is apparently essential for the uptake of NBMPR and purine beta-L-nucleosides by intracellular Toxoplasma and Toxoplasma-infected cells. These results also demonstrate that, in contrast to the mammalian nucleoside transporters, the Toxoplasma adenosine/purine nucleoside transporter(s) lacks stereospecificity and substrate specificity in the transport of purine nucleosides. In addition, infection with T. gondii confers the properties of the parasite's purine nucleoside transport on the parasitized host cells and enables the infected cells to transport purine nucleosides that were not transported by uninfected cells. These unique characteristics of purine nucleoside transport in T. gondii may aid in the identification of new promising antitoxoplasmic drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506037      PMCID: PMC201154          DOI: 10.1128/AAC.47.10.3247-3251.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Metabolism of adenosine analogues by Schistosoma mansoni and the effect of nucleoside transport inhibitors.

Authors:  M H el Kouni; S Cha
Journal:  Biochem Pharmacol       Date:  1987-04-01       Impact factor: 5.858

2.  Effect of nitrobenzylthioinosinate on the toxicity of tubercidin and ethidium against Trypanosoma gambiense.

Authors:  P O Ogbunude; C O Ikediobi
Journal:  Acta Trop       Date:  1982-09       Impact factor: 3.112

3.  Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate.

Authors:  M H el Kouni; D Diop; S Cha
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  Identification and characterisation of high affinity nucleoside and nucleobase transporters in Toxoplasma gondii.

Authors:  Harry P De Koning; Mohammed I Al-Salabi; Adrian M Cohen; Graham H Coombs; Jonathan M Wastling
Journal:  Int J Parasitol       Date:  2003-07-30       Impact factor: 3.981

5.  Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.

Authors:  M H el Kouni; N J Messier; S Cha
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

6.  Stage-specific alteration of nucleoside membrane permeability and nitrobenzylthioinosine insensitivity in Plasmodium falciparum infected erythrocytes.

Authors:  A M Gero; E M Bugledich; A R Paterson; G P Jamieson
Journal:  Mol Biochem Parasitol       Date:  1988-01-15       Impact factor: 1.759

7.  Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis.

Authors:  M H el Kouni; D Diop; P O'Shea; R Carlisle; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

8.  Nucleoside permeation in mouse erythrocytes infected with Plasmodium yoelii.

Authors:  W P Gati; A F Stoyke; A M Gero; A R Paterson
Journal:  Biochem Biophys Res Commun       Date:  1987-06-30       Impact factor: 3.575

Review 9.  Potential chemotherapeutic targets in the purine metabolism of parasites.

Authors:  Mahmoud H el Kouni
Journal:  Pharmacol Ther       Date:  2003-09       Impact factor: 12.310

10.  Combination therapy of Schistosoma japonicum by tubercidin and nitrobenzylthioinosine 5'-monophosphate.

Authors:  M H el Kouni; P M Knopf; S M Cha
Journal:  Biochem Pharmacol       Date:  1985-11-01       Impact factor: 5.858

View more
  6 in total

Review 1.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

2.  Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

3.  Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine.

Authors:  Fardos N M Naguib; Reem H Rais; Omar N Al Safarjalani; Mahmoud H el Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2015-06-23       Impact factor: 2.231

4.  Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.

Authors:  Young Ah Kim; Ashoke Sharon; Chung K Chu; Reem H Rais; Omar N Al Safarjalani; Fardos N M Naguib; Mahmoud H el Kouni
Journal:  Biochem Pharmacol       Date:  2007-01-21       Impact factor: 5.858

5.  Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.

Authors:  Zhengxiang Zhu; John K Buolamwini
Journal:  Bioorg Med Chem       Date:  2008-01-30       Impact factor: 3.641

6.  7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H el Kouni
Journal:  Biochem Pharmacol       Date:  2008-08-07       Impact factor: 5.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.